Total Payments
$4,820
2024 Payments
$625.72
Companies
20
Transactions
312
Medicare Patients
703
Medicare Billing
$74,988
Payment Breakdown by Category
Food & Beverage$4,645 (96.4%)
Education$174.27 (3.6%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,645 | 309 | 96.4% |
| Education | $174.27 | 3 | 3.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $1,073 | 87 | $0 (2024) |
| ABBVIE INC. | $1,008 | 64 | $0 (2024) |
| Janssen Biotech, Inc. | $733.55 | 42 | $0 (2024) |
| Gilead Sciences, Inc. | $380.01 | 23 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $369.47 | 27 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $200.68 | 7 | $0 (2024) |
| GENZYME CORPORATION | $200.34 | 11 | $0 (2024) |
| Echosens North America, Inc. | $157.43 | 3 | $0 (2024) |
| Biohaven Pharmaceutical Holding Company Ltd. | $130.05 | 11 | $0 (2022) |
| Daiichi Sankyo Inc. | $103.79 | 7 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $625.72 | 29 | Echosens North America, Inc. ($157.43) |
| 2023 | $895.15 | 52 | ABBVIE INC. ($273.77) |
| 2022 | $1,171 | 84 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($270.29) |
| 2021 | $850.58 | 59 | AbbVie Inc. ($266.18) |
| 2020 | $883.86 | 62 | Janssen Biotech, Inc. ($288.73) |
| 2019 | $393.03 | 26 | Gilead Sciences, Inc. ($121.91) |
All Payment Transactions
312 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/11/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $16.88 | General |
| Category: Gastroenterology | ||||||
| 06/26/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), PLENVU | Food and Beverage | In-kind items and services | $12.10 | General |
| Category: Gastroenterology | ||||||
| 06/03/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $22.14 | General |
| Category: Immunology | ||||||
| 05/30/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), PLENVU | Food and Beverage | In-kind items and services | $11.23 | General |
| Category: Gastroenterology | ||||||
| 05/22/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $19.32 | General |
| Category: Gastroenterology | ||||||
| 05/13/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), XIFAXAN | Food and Beverage | In-kind items and services | $11.14 | General |
| Category: Gastroenterology | ||||||
| 05/06/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $13.72 | General |
| Category: Immunology | ||||||
| 04/29/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $18.76 | General |
| Category: INTERNAL MEDICINE | ||||||
| 04/24/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), PLENVU | Food and Beverage | In-kind items and services | $10.14 | General |
| Category: Gastroenterology | ||||||
| 04/23/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $18.78 | General |
| Category: Immunology | ||||||
| 04/18/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $15.38 | General |
| Category: Immunology | ||||||
| 04/10/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $23.14 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 04/08/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $27.95 | General |
| Category: IMMUNOLOGY | ||||||
| 04/03/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.42 | General |
| Category: Gastroenterology | ||||||
| 04/02/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $20.45 | General |
| Category: Cardio-renal | ||||||
| 03/20/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $16.18 | General |
| Category: Immunology | ||||||
| 03/20/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), PLENVU | Food and Beverage | In-kind items and services | $15.05 | General |
| Category: Gastroenterology | ||||||
| 03/18/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $20.41 | General |
| Category: THERAPY FOR CSID | ||||||
| 03/14/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $20.94 | General |
| Category: Immunology | ||||||
| 03/07/2024 | Echosens North America, Inc. | FibroScan (Device) | Food and Beverage | Cash or cash equivalent | $7.52 | General |
| Category: Elastography | ||||||
| 03/06/2024 | Echosens North America, Inc. | FibroScan (Device) | Food and Beverage | Cash or cash equivalent | $50.50 | General |
| Category: Elastography | ||||||
| 03/04/2024 | Echosens North America, Inc. | FibroScan (Device) | Food and Beverage | Cash or cash equivalent | $99.41 | General |
| Category: Elastography | ||||||
| 03/04/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $19.22 | General |
| Category: Immunology | ||||||
| 02/27/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $23.24 | General |
| 02/22/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $19.38 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 246 | 257 | $277,761 | $27,328 |
| 2022 | 8 | 242 | 257 | $233,782 | $24,701 |
| 2021 | 6 | 106 | 127 | $105,136 | $11,898 |
| 2020 | 4 | 109 | 131 | $114,354 | $11,061 |
Total Patients
703
Total Services
772
Medicare Billing
$74,988
Procedure Codes
26
All Medicare Procedures & Services
26 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 41 | 42 | $72,702 | $7,654 | 10.5% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 95 | 102 | $100,266 | $7,545 | 7.5% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 32 | 32 | $39,744 | $3,875 | 9.7% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 15 | 15 | $18,630 | $2,540 | 13.6% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 20 | 20 | $28,240 | $2,050 | 7.3% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 17 | 18 | $3,996 | $1,686 | 42.2% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 15 | 17 | $2,754 | $1,088 | 39.5% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 11 | 11 | $11,429 | $891.21 | 7.8% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 34 | 34 | $58,854 | $6,438 | 10.9% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 80 | 83 | $81,589 | $5,939 | 7.3% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 36 | 36 | $8,388 | $3,536 | 42.2% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2022 | 26 | 26 | $32,292 | $3,521 | 10.9% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 25 | 25 | $35,300 | $2,699 | 7.6% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 12 | 12 | $12,468 | $893.56 | 7.2% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 17 | 29 | $2,755 | $863.23 | 31.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 12 | 12 | $2,136 | $810.98 | 38.0% |
| 45385 | Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare | Facility | 2021 | 15 | 15 | $25,965 | $2,950 | 11.4% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 36 | 39 | $38,337 | $2,513 | 6.6% |
| 45378 | Diagnostic examination of the colon (large bowel) using an endoscope(colonoscopy); high risk | Facility | 2021 | 13 | 14 | $17,388 | $1,900 | 10.9% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 18 | 18 | $4,194 | $1,883 | 44.9% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 13 | 30 | $3,720 | $1,659 | 44.6% |
| 45380 | Biopsy of the large bowel using an endoscope (colonoscopy) | Facility | 2021 | 11 | 11 | $15,532 | $993.10 | 6.4% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2020 | 50 | 52 | $51,116 | $3,381 | 6.6% |
| 45380 | Biopsy of large bowel using an endoscope | Facility | 2020 | 25 | 25 | $35,300 | $3,089 | 8.8% |
| 45378 | Diagnostic examination of large bowel using an endoscope | Facility | 2020 | 19 | 19 | $23,598 | $2,634 | 11.2% |
About Dr. Thomas Moore, MD
Dr. Thomas Moore, MD is a Gastroenterology healthcare provider based in Corbin, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/19/2006. The National Provider Identifier (NPI) number assigned to this provider is 1235211616.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Thomas Moore, MD has received a total of $4,820 in payments from pharmaceutical and medical device companies, with $625.72 received in 2024. These payments were reported across 312 transactions from 20 companies. The most common payment nature is "Food and Beverage" ($4,645).
As a Medicare-enrolled provider, Moore has provided services to 703 Medicare beneficiaries, totaling 772 services with total Medicare billing of $74,988. Data is available for 4 years (2020–2023), covering 26 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Corbin, KY
- Active Since 10/19/2006
- Last Updated 07/29/2021
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1235211616
Products in Payments
- STELARA (Biological) $647.23
- XIFAXAN (Drug) $608.69
- TRULANCE (Drug) $404.48
- DUPIXENT (Biological) $401.02
- MAVYRET (Drug) $370.90
- ENTYVIO (Biological) $272.67
- RINVOQ (Biological) $214.91
- NURTEC ODT (Drug) $177.36
- CREON (Drug) $170.58
- FibroScan (Device) $157.43
- INJECTAFER (Drug) $103.79
- Aimovig (Biological) $101.01
- LINZESS (Drug) $87.23
- REMICADE (Biological) $86.32
- VIBERZI (Drug) $80.97
- MOTEGRITY (Drug) $65.62
- PLENVU (Drug) $59.70
- Kerendia (Drug) $59.51
- Vascepa (Drug) $55.32
- SKYRIZI (Biological) $50.66
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.